ChronicleBio
ChronicleBio provides an AI-powered data platform to accelerate diagnosis and treatment for complex neuroimmune disorders. It integrates multi-omic, phenotypic, and clinical data in a decentralized research ecosystem and AI-ready data lake, enabling biomarker discovery, patient stratification, and drug repurposing. The platform supports researchers, sponsors, and healthcare partners with trial design, site activation, and diverse patient enrollment. Key technologies include AI, machine learning, data harmonization, and biobank integration to generate actionable insights and proprietary intellectual property. The approach aims to shorten research timelines and advance diagnostics and therapies for these conditions.
ChronicleBio
ChronicleBio provides an AI-powered data platform to accelerate diagnosis and treatment for complex neuroimmune disorders. It integrates multi-omic, phenotypic, and clinical data in a decentralized research ecosystem and AI-ready data lake, enabling biomarker discovery, patient stratification, and drug repurposing. The platform supports researchers, sponsors, and healthcare partners with trial design, site activation, and diverse patient enrollment. Key technologies include AI, machine learning, data harmonization, and biobank integration to generate actionable insights and proprietary intellectual property. The approach aims to shorten research timelines and advance diagnostics and therapies for these conditions.